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13-year-old tuberous sclerosis patient with renal
cell carcinoma associated with multiple renal
angiomyolipomas developing multifocal
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Abstract
Background: The autosomal dominant tumor syndrome tuberous sclerosis complex is caused by the mutated
TSC1 gene, hamartin, and the TSC2 gene, tuberin. Patients with this complex develop typical cutaneus symptoms
such as peau chagrin or angiofibromas of the skin as well as other lesions such as astrocytomas in the brain and
lymphangioleiomyomatosis in the lung. Only a few tuberous sclerosis patients have been described who showed a
multifocal micronodular pneumocyte hyperplasia of the lung. Another benign tumor which often occurs together
with tuberous sclerosis is the angiomyolipoma of the kidney. Furthermore, an increased incidence of renal cell
carcinoma in connection with tuberous sclerosis has also been proven.
Case presentation: We report a 13-year-old white girl with epilepsy and hypopigmented skin lesions. Radiological
studies demonstrated the typical cortical tubers leading to the diagnosis of tuberous sclerosis. In the following
examinations a large number of angiomyolipomas were found in both kidneys. One lesion showed an increasing
size and tumor like aspects in magnetic resonance imaging. The pathological examination of the following
tumorectomy demonstrated an unclassified renal cell carcinoma. Four months postoperatively, a follow-up
computer tomography revealed multiple bilateral pulmonary nodules. To exclude lung metastases of the renal cell
carcinoma, multiple open-lung biopsies were performed.
Conclusion: Here we report a diagnostically challenging case of a 13-year-old patient with tuberous sclerosis and
angiomyolipomas of the kidney who developed an unclassified renal cell carcinoma as well as multifocal
micronodular pneumocyte hyperplasia.
Keywords: Multifocal micronodular pneumocyte hyperplasia (MMPH), Renal cell carcinoma, Angioleiomyolipoma,
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Background
The TSC1 gene, hamartin, and the TSC2 gene, tuberin,
were identified in 1997 and 1993, respectively. These
tumor suppressor genes are mutated in the autosomal
dominant tumor syndrome tuberous sclerosis complex
(TSC) [1-3]. TSC is characterized by the formation of
hamartomatous lesions in multiple organ systems.
Besides the typical skin manifestations, e.g. cutaneous
angiofibroma, peau chagrin, or subungual fibromas, TSC
patients develop numerous brain lesions such as cortical
tubers and subependymal giant cell astrocytomas. In
addition, patients show an increased incidence of benign
tumors such as multiple renal angiomyolipomas (AMLs),
lymphangioleiomyomatosis (LAM) of the lungs, cardiac
rhabdomyomas, and adenomatous polyps of the duode-
num and the small intestine. Another rare manifestation
of TSC is the so-called multifocal micronodular pneu-
mocyte hyperplasia (MMPH), first recognized in 1991 by
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HH Popper [4]. TSC is also associated with an increased
incidence of renal cell carcinomas (RCC) [5].
In this report, we present a case of a young patient
with TSC and multiple AMLs who developed a RCC as
well as MMPH. We discuss the histological, immunohis-
tological and molecular features of these lesions with




The patient was a 13-year-old Caucasian girl who suffered
from epilepsy in the form of salaam seizures that had
begun at the age of 6 months. Aside from the seizures,
clinical examination revealed hypopigmented skin lesions
on the face and abdomen which were classified as peau
chagrin. In addition, radiologic studies demonstrated the
typical cortical tubers which led to the diagnosis of TSC.
In the annual follow-up routine examinations, a large
number of blurred coin lesions in both kidneys were
found which were classified as multiple AMLs in the con-
text of TSC. At the age of 13, one coin lesion showed an
increase in size and magnetic resonance imaging (MRI)
demonstrated a 3.5-cm tumor in the left kidney (Figure 1A
and B), upon which the the patient underwent tumorect-
omy of that kidney. The postoperative period was unevent-
ful and the patient was discharged 7 days after surgery.
Four months postoperatively, a follow-up CT scan of the
chest revealed multiple bilateral pulmonary nodules meas-
uring 1–6 mm (Figure 2A). Due to the RCC diagnosis, and
also to rule out lung metastases, follow-up chest CT scans
were performed after 6 and 9 months, showing an un-
changed status of the pulmonary nodules in terms of size
and number, with CT-morphological appearances typical
of MMPH.One year after the renal tumor resection, mul-
tiple open lung biopsies of both lungs were performed to
obtain histological evidence. After an uneventful recovery
the patient was discharged after 5 days.
A B
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Figure 1 Morphology of renal tumors. A coronary (A) and axial (B) magnetic resonance imaging (MRI) scan of the kidneys showing multiple
cysts and a tumor in the left kidney measuring 3.5 cm in diameter. Histologically, the renal cell carcinoma was composed of solid and nested
tumor cells with voluminous clear cytoplasm (C, x200) and strong expression of P504s (D, x100). The AMLs demonstrated the pathognomonic
components of this tumor entity, mature fat and blood vessels (E, x40 / F, x100).
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Pathological findings of the renal tumors
Macroscopically, the tumorectomy revealed a 5 cm
yellowish red tumor with multiple 1 to 2 mm yellow no-
dules in the adjacent kidney tissue.
The 5 cm tumor of the kidney showed a solid and
nested, sometimes papillary architecture, and was com-
posed of clear cells with voluminous cytoplasm, discrete
cell borders, and vesicular chromatin. In addition, psam-
momatous calcification and hyaline nodules could be
detected (Figure 1C). Immunohistochemical examinations
revealed a weak to strong staining for vimentin and CD10
in more than 50% of neoplastic cells. All tumor cells
showed a strong staining for P504s (Figure 1D). Pan-CK
was only weakly expressed in scattered tumor cells. CK7
or HMB-45 could not be shown in the carcinoma cells.
Based on the morphological and immunohistochemical
findings, it was hypothesized that the tumor might be a
RCC of XP 11.2 translocation type. This hypothesis was
confirmed by three independent consultant pathologists








Figure 2 Morphology of pulmonary lesions. Axial (A) computer tomography (CT) of the chest revealed multiple soft tissue density nodules of
1–6 mm in diameter in both lungs with a minimal peripheral ground glass component in a random peribronchovascular-centrilobular
distribution pattern. There was slight size predominance in the lower lung zones with the largest nodules being located in the middle and lower
lobes. Furthermore, there was moderate regional air trapping in the basal lower lobes. Histologically and immunohistologically, nodules were
composed of proliferated and enlarged type II pneumocytes (B, x40 /C, E, G x100) expressing pan-CK (E, x100), TTF-1 (F, x100) with low
proliferation rate in Ki67 (H, x100).
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Germany; Moch H, Department of Surgical Pathology,
University of Zürich, Switzerland; and Argami P, De-
partment of Pathology, The Johns Hopkins University,
Baltimore, USA); however, a typical expression of TFE3
and TFEB could not be demonstrated. Comparative
genome hybridization (CGH) analysis did not reveal
chromosomal imbalances such as losses at 3p or gains
at 17q specific for clear cell RCC or papillary RCC, re-
spectively (data not shown).
Besides the 5 cm tumor, multiple 1 to 2 mm nodules
were observed in the adjacent renal tissue, which showed
the 3 components of AMLs and the typical immunohisto-
chemically expression of HMB-45 (Figure 1E and F).
Pathological findings of the lung tumors
Macroscopically, open-lung biopsies revealed 2 to 5 mm
sharply demarcated and randomly distributed nodules in
both lungs (Figure 2A).
The nodules were composed of proliferated and
enlarged type II pneumocytes which had abundant eo-
sinophilic cytoplasm and vesicular nuclei with promin-
ent nucleoli and occasional eosinophilic inclusions. The
cells formed ill-defined areas of papillae that filled the al-
veolar space and partly obscured the alveolar architec-
ture. Significant atypia or mitosis could not be observed.
The interalveolar septa were mild thickened with in-
creased reticulin (Figure 2B, C, E, G). Immunohisto-
chemically, the hyperplastic epithelial cells showed an
expression of pan-CK, TTF-1 (Figure 2D, F), and EMA,
whereas stains for HMB-45, actin, vimentin and ER were
uniformly negative. The proliferation rate evaluated with
MIB-1 was solely 2% (Figure 2H).
Conclusion
TSC is an autosomal-dominant disorder characterized by a
variably high incidence (90-95%) affecting 0.5-1 per 10,000
births. The diagnosis of TSC is currently made by using
the criteria established by Gomez [6]. These criteria are
composed of primary (e.g. subependymal nodes and facial
angiofibroma), secondary, (e.g. AMLs and LAM), and ter-
tiary features (e.g. hypomelanotic maculas). Whereas the
hamartomas in TSC are benign lesions, other phakoma-
toses such as Von-Hippel-Lindau (VHL) disease are cha-
racterized by the development of malignant tumors.
Therefore, RCC is a typical malignant tumor that is known
to arise in VHL, whereas tuberous TSC patients also de-
velop RCC, but only in rare cases [5]. The mechanisms
behind the occurrence of RCC could be demonstrated in
the Eker rat model which develops RCCs based on a muta-
tion in TSC2 gene [7-9]. Furthermore, an unusual pulmo-
nary manifestation of TSC is MMPH, typically presenting
multiple pulmonary nodules on chest roentgenogram or
CT scan [4,10,11].
The case described here shows the diagnostic chal-
lenge of young TSC patients who present with multiple
AMLs of the kidney and develop an unclassified RCC.
RCC often occur in young TSC patients [12,13] and
demonstrate several subtypes [14]. In our case, in the
follow-up months a CT scan revealed multiple nodules
in the lungs. It is difficult to differentiate between benign
lesions like LAM or MMPH and metastasis on the basis
of CT scans only, as our present case demonstrates [15].
A definitive diagnosis of MMPH could only be made on
the basis of histological examination of a lung biopsy.
MMPH is extremely rare in TSC and in the literature
less than 20 histologically documented cases are des-
cribed and have been reported in association with LAM
and AML [16]. One of these cases shows MMPH in a
TSC patient who had undergone a bilateral nephrectomy
because of RCC. AML are not reported in this case, but
the authors also describe the difficulty they had differen-
tiating between the benign MMPH and metastasis of the
RCC [17].
The association between TSC mutation and RCC seems
to be often underestimated in familiarly RCC [18]. Further-
more, the TSC 1/2 complex influences the beta-catenin
pathway and could also play a functional role in other he-
reditary tumor syndromes such as Cowden’s disease or
Peutz-Jeghers syndrome [19].
The case of a young TSC patient described here demon-
strates a rare combination of AMLs, RCC and hamarto-
mas in the lung, which posed a diagnostic dilemma.
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